Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Pituitary Neoplasms 3Neoplasms 2Liver Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Supratentorial Neoplasms 1Sleep Initiation and Maintenance Disorders 1Rectal Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Lung Neoplasms 1Kidney Neoplasms 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Colonic Neoplasms 1Chronic Pain 1Agnosia 1Abdominal Neoplasms 1Abdominal Cancer Surgery 1Abdominal Cancer Surgeries 1

Interventions

Radiofrequency Ablation 4gadolinium ethoxybenzyl DTPA 2atezolizumab 2Sorafenib 2Oxaliplatin 2Fluorouracil 2Dexmedetomidine 2Bevacizumab 2voxilaprevir 1velpatasvir 1huachansu 1entecavir 1Tobacco Use Cessation Devices 1Tinzaparin 1Telbivudine 1Technetium Tc 99m Aggregated Albumin 1Sofosbuvir 1Sevoflurane 1Ribavirin 1Radionuclide Generators 1Psychiatric Rehabilitation 1Propofol 1Pregabalin 1Polymerase Chain Reaction 1Nivolumab 1Neuroleptanalgesia 1Lamivudine 1Immunotherapy 1Gene Expression Profiling 1Galactose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Liver Neoplasms × Dexmedetomidine × Clear all
NCT02044224 2015-10-20

Effects of Dexmedetomidine During IRE Procedures for Solid Tumours

Uppsala University Hospital

Phase 4 Completed
30 enrolled
Gastrointestinal

Liver Neoplasms, Pancreatic Neoplasms

NCT02016391 2014-12-17

Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours

Uppsala University Hospital

Phase 4 Completed
50 enrolled
GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡